Skip to main
MOH
MOH logo

Molina Healthcare (MOH) Stock Forecast & Price Target

Molina Healthcare (MOH) Analyst Ratings

Based on 11 analyst ratings
Hold
Strong Buy 0%
Buy 27%
Hold 73%
Sell 0%
Strong Sell 0%

Bulls say

Molina Healthcare demonstrated strong performance in its Medicare segment, with membership and revenue exceeding expectations, and a Managed Care Ratio (MCR) of 90.0% reflecting an increase linked to higher utilization in acute populations. The Medicaid segment also showed resilience, with an MCR of 91.3% which increased year-over-year and sequentially, driven by elevated utilization among new and renewing members, despite some pressure from specific areas. These positive metrics across key segments suggest a solid foundation for continued revenue growth and operational efficiency, contributing to a favorable outlook for the company.

Bears say

Molina Healthcare's outlook for the marketplace segment is deteriorating significantly, indicating a challenging environment that is reflected in the recent guidance revisions. The second-quarter results highlighted accelerating medical cost pressures across all business lines, necessitating a cut to financial estimates and a shift in outlook. The anticipated risk deterioration in the health insurance exchange (HIX) programs, paired with expected market shrinkage, suggests potential further strain on profitability moving into 2026.

Molina Healthcare (MOH) has been analyzed by 11 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 27% recommend Buy, 73% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Molina Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Molina Healthcare (MOH) Forecast

Analysts have given Molina Healthcare (MOH) a Hold based on their latest research and market trends.

According to 11 analysts, Molina Healthcare (MOH) has a Hold consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $228.18, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $228.18, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Molina Healthcare (MOH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.